Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $1797.0.

  • iSpecimen's Share-based Compensation fell 9724.14% to $1797.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $30473.0, marking a year-over-year decrease of 8931.82%. This contributed to the annual value of $249675.0 for FY2024, which is 4568.34% down from last year.
  • iSpecimen's Share-based Compensation amounted to $1797.0 in Q3 2025, which was down 9724.14% from $1803.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Share-based Compensation registered a high of $399821.0 during Q3 2021, and its lowest value of $1797.0 during Q3 2025.
  • Its 5-year average for Share-based Compensation is $98623.6, with a median of $65141.0 in 2024.
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 130066.03% in 2021, then tumbled by 9724.14% in 2025.
  • iSpecimen's Share-based Compensation (Quarter) stood at $171833.0 in 2021, then tumbled by 73.73% to $45138.0 in 2022, then skyrocketed by 139.53% to $108119.0 in 2023, then plummeted by 89.85% to $10972.0 in 2024, then plummeted by 83.62% to $1797.0 in 2025.
  • Its last three reported values are $1797.0 in Q3 2025, $1803.0 for Q2 2025, and $15901.0 during Q1 2025.